Cargando…

Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease

INTRODUCTION: To improve our understanding of sex differences in the clinical characteristics of Parkinson’s Disease, we sought to examine differences in the clinical features and disease severity of men and women with early treated Parkinson’s Disease (PD) enrolled in a large-scale clinical trial....

Descripción completa

Detalles Bibliográficos
Autores principales:	Augustine, Erika F., Pérez, Adriana, Dhall, Rohit, Umeh, Chizoba C., Videnovic, Aleksandar, Cambi, Franca, Wills, Anne-Marie A., Elm, Jordan J., Zweig, Richard M., Shulman, Lisa M., Nance, Martha A., Bainbridge, Jacquelyn, Suchowersky, Oksana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501841/ https://www.ncbi.nlm.nih.gov/pubmed/26171861 http://dx.doi.org/10.1371/journal.pone.0133002

Ejemplares similares

No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial
por: Umeh, Chizoba C., et al.
Publicado: (2014)

Circadian dysregulation in Parkinson's disease
por: Videnovic, Aleksandar, et al.
Publicado: (2016)

Dopamine Transporter Imaging in Psychogenic Parkinsonism and Neurodegenerative Parkinsonism with Psychogenic Overlay: A Report of Three Cases
por: Umeh, Chizoba C., et al.
Publicado: (2013)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

Sleep and circadian rhythms in Parkinson’s disease and preclinical models
por: Hunt, Jeremy, et al.
Publicado: (2022)

Impact of outpatient gastroenterology consult on pharmacotherapy and management of gastrointestinal symptoms in Parkinson’s Disease
por: Chang, Jocelyn J., et al.
Publicado: (2023)

Obstacle Avoidance amongst Parkinson Disease Patients Is Challenged in a Threatening Context
por: Doan, Jon B., et al.
Publicado: (2013)

Olfactory Deficits in the Freezing of Gait Phenotype of Parkinson's Disease
por: Glover, Aliyah, et al.
Publicado: (2021)

REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis
por: Mahajan, Abhimanyu, et al.
Publicado: (2014)

Sleep and clocks – implications for brain health
por: Musiek, Erik S., et al.
Publicado: (2017)

Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update
por: Fifel, Karim, et al.
Publicado: (2021)

Early Freezing of Gait: Atypical versus Typical Parkinson Disorders
por: Lieberman, Abraham, et al.
Publicado: (2015)

Utility of objective gait measures in levodopa‐unresponsive freezing in Parkinson's
por: Virmani, Tuhin, et al.
Publicado: (2021)

A Mobile Cloud-Based Parkinson’s Disease Assessment System for Home-Based Monitoring
por: Pan, Di, et al.
Publicado: (2015)

Walking with Music Is a Safe and Viable Tool for Gait Training in Parkinson's Disease: The Effect of a 13-Week Feasibility Study on Single and Dual Task Walking
por: de Bruin, Natalie, et al.
Publicado: (2010)

Chronic sleep disturbance and neural injury: links to neurodegenerative disease
por: Abbott, Sabra M, et al.
Publicado: (2016)

Sleep Disorders and Circadian Disruption in Huntington’s Disease
por: Saade-Lemus, Sandra, et al.
Publicado: (2023)

Depleting implanted pulse generator (IPG) battery voltage is associated with worsening clinical symptoms in movement disorder patients receiving Deep brain stimulation (DBS)
por: Hamed, Moath, et al.
Publicado: (2019)

Dual Treatment of Hemichorea–Hemiballismus Syndrome with Tetrabenazine and Chemodenervation
por: Umeh, Chizoba C., et al.
Publicado: (2012)

Understanding Internal Accountability in Nigeria’s Routine Immunization System: Perspectives From Government Officials at the National, State, and Local Levels
por: Erchick, Daniel J., et al.
Publicado: (2016)

Sleep Neurology’s Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation
por: St Louis, Erik K., et al.
Publicado: (2021)

Sodium oxybate—a new horizon for symptomatic treatment of RBD?
por: Stefani, Ambra, et al.
Publicado: (2023)

Sex specific cognitive differences in Parkinson disease
por: Reekes, Tyler Harrison, et al.
Publicado: (2020)

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations
por: Morgan, John C., et al.
Publicado: (2018)

Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease
por: Chen, Xiqun, et al.
Publicado: (2018)

Impedance trend from a symptomatic perielectrode cystic cavity following deep brain stimulation: illustrative case
por: Elberson, Brooke, et al.
Publicado: (2023)

Qualitative Evaluation of the Personal KinetiGraph(TM) Movement Recording System in a Parkinson’s Clinic
por: Santiago, Anthony, et al.
Publicado: (2019)

Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists
por: Alcalay, Roy N., et al.
Publicado: (2019)

Correction: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists
por: Alcalay, Roy N., et al.
Publicado: (2019)

PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes
por: Wang, Erming, et al.
Publicado: (2007)

Coordinated Reset Vibrotactile Stimulation Induces Sustained Cumulative Benefits in Parkinson’s Disease
por: Pfeifer, Kristina J., et al.
Publicado: (2021)

Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
por: Videnovic, Aleksandar, et al.
Publicado: (2021)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2015)

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
por: Latourelle, Jeanne C, et al.
Publicado: (2008)

Tools for communicating risk for Parkinson’s disease
por: Cook, Lola, et al.
Publicado: (2022)

Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease
por: Creanor, Siobhan, et al.
Publicado: (2015)

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results
por: Fernandez, Hubert H, et al.
Publicado: (2015)

Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals
por: Yang, Yuzhe, et al.
Publicado: (2022)

White matter microstructure in Parkinson’s disease with and without elevated rapid eye movement sleep muscle tone
por: Patriat, Rémi, et al.
Publicado: (2022)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p040q1u0qvacf0v505tjdsfcb5